MetLife (NYSE:MET) Stock: Insider Michel Khalaf Sells 187,425 Shares

Posted by Hanz Christensen on Nov 14th, 2026

MetLife, Inc. (NYSE:MET – Get Free Report) CEO Michel Khalaf sold 187,425 shares of MetLife stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the sale, the chief executive officer owned 759,013 shares of the company’s stock, valued at approximately $78,155,568.61. This trade represents a 19.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

MetLife Stock Performance

Shares of NYSE MET opened at $102.67 on Friday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.20 and a current ratio of 0.21. The stock has a fifty day moving average price of $98.75 and a two-hundred day moving average price of $86.90. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $106.72. The firm has a market cap of $64.52 billion, a P/E ratio of 9.91, a PEG ratio of 0.96 and a beta of 0.79.

MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.77 by $0.01. The business had revenue of $20.52 billion during the quarter, compared to analyst estimates of $19.86 billion. MetLife had a return on equity of 25.71% and a net margin of 6.21%. MetLife’s quarterly revenue was up 18.2% compared to the same quarter last year. During the same period last year, the company earned $2.34 earnings per share. Research analysts forecast that MetLife, Inc. will post 9.91 EPS for the current fiscal year.

MetLife declared that its board has initiated a share buyback program on Wednesday, August 5th that permits the company to repurchase $3 billion in shares. This buyback authorization permits the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be paid a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, November 3rd. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.3%. MetLife’s dividend payout ratio is 30.90%.

Analysts Set New Price Targets

A number of brokerages have recently commented on MET. Evercore reiterated a “mixed” rating on shares of MetLife in a research note on Monday, August 24th. UBS Group raised their price objective on shares of MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, October 6th. Weiss Ratings upgraded shares of MetLife from a “buy (b)” rating to a “buy (b+)” rating in a research note on Monday. Barclays raised their price target on MetLife from $97.00 to $111.00 and gave the stock an “overweight” rating in a report on Wednesday, October 7th. Finally, Mizuho lifted their price target on MetLife from $112.00 to $117.00 and gave the stock an “outperform” rating in a research note on Thursday. Fourteen analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $107.12.

Get Our Latest Stock Report on MetLife

Institutional Investors Weigh In On MetLife

A number of institutional investors have recently bought and sold shares of MET. CX Institutional lifted its stake in shares of MetLife by 1.3% in the 3rd quarter. CX Institutional now owns 8,672 shares of the financial services provider’s stock valued at $817,000 after purchasing an additional 115 shares during the period. Investment Research Partners LLC boosted its position in shares of MetLife by 3.9% during the 3rd quarter. Investment Research Partners LLC now owns 3,103 shares of the financial services provider’s stock valued at $292,000 after acquiring an additional 116 shares during the last quarter. McGlone Suttner Wealth Management Inc. lifted its holdings in shares of MetLife by 0.6% in the 3rd quarter. McGlone Suttner Wealth Management Inc. now owns 22,391 shares of the financial services provider’s stock worth $2,108,000 after acquiring an additional 124 shares during the last quarter. International Private Wealth Advisors LLC raised its holdings in shares of MetLife by 3.1% during the third quarter. International Private Wealth Advisors LLC now owns 4,223 shares of the financial services provider’s stock valued at $398,000 after acquiring an additional 126 shares in the last quarter. Finally, Capital Analysts LLC grew its stake in shares of MetLife by 0.3% in the second quarter. Capital Analysts LLC now owns 38,262 shares of the financial services provider’s stock worth $3,238,000 after acquiring an additional 129 shares during the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

About MetLife

(Get Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.